Facebook is changing up its News Feed, a new twist in the "All the Money in the World" wage gap controversy, and Lindsay Lohan might design a manmade island in Dubai. Plus, wrapping up the biggest headlines from CES with Wired, celebrity fashion designer Isaac Mizrahi, and the star of Amazon's "Philip K. Dick's Electric Dreams."
Plus, why YouTube took two weeks to punish Logan Paul after posting a video of an apparent suicide victim. We also break down Nintendo's surprise announcement of new games coming to Switch in 2018. Marvel's television future is in question after an ABC executive suggested "Inhumans" is due for cancellation.
We speak with Vogue.com about E!'s future in the Time's Up era. Then, it's Your Future Home brought to you by Rocket Mortgage by Quicken Loans. We discuss your future robot realtor and how to win in a bidding war.
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Two of the top low-cost online retailers are going head to head in a new legal battle. Cheddar News' Michelle Castillo breaks the lawsuit down.
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
